New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 10, 2016 – The FDA approved Merz’s Naftin (naftifine) 2% cream, to include additional data in pediatric subjects aged 2 years to 17 years 11 months with tinea corporis.
Download PDF
Return to publications
